Ranjita Shegokar Ph.D.

Dr. Ranjita Shegokar

linkedin X ResearchGate Logo sundirect pubmed amezon google
Menu

Dr. Ranjita Shegokar

Menu
  • Home
  • Uncategorized
  • 20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications
Image

20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications

The scientific community considers the lipid nanoparticles as very promising delivery system, as shown by the many research groups working meanwhile with SLN and NLC. Lipid nanoparticles already made it to the cosmetic market. This proves the makeability of products and of large scale production ability – both being important prerequisites for a pharmaceutical product. Various companies are working with these nanoparticles, and this decade will now show if the lipid nanoparticles reach the final goal: pharmaceutical products.
https://doi.org/10.2174/157016311796799062
20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications

Related Posts

Zeta Potential of Positively Charged Lipid Nanoparticle
Uncategorized

Zeta Potential of Positively Charged Lipid Nanoparticle

Zeta potential of positively charged lipid nanoparticle. Zeta Potential of Positively Charged Lipid Nanoparticle

ByByRanjitasMay 7, 2024
Dermal Targeting and Protective Mechanism
Uncategorized

Dermal Targeting and Protective Mechanism

Dermal targeting and protective mechanism by application of lipid nanoparticle. Dermal Targeting and Protective Mechanism

ByByRanjitasMay 7, 2024
Organ Targeting of Nanocrystals
Uncategorized

Organ Targeting of Nanocrystals

Organ targeting of nanocrystals depicted by Gamma scintigraphy. Transmission electron microscopy clearly indicates penetration of drug loaded polymeric…

ByByRanjitasMay 7, 2024
A Positron Emission Tomography (PET)
Uncategorized

A Positron Emission Tomography (PET)

A positron emission tomography (PET) scan is an imaging test that can help reveal the metabolic or biochemical…

ByByRanjitasMay 7, 2024

German Innovation Award

Dr. Ranjita Shegokar, CSO was honored with a German Innovation Award 2022 jointly with Prof. Marc A. Reymond, MD MBA (AACSB), CEO, CapnoPharm GmbH, for their collaborative, innovative research work in the field of cancer. https://www.german-innovation-award.de/en/winners/
preis/gewinner/capnopen-capnodrugs/

ACES Award

German medical device firm races to provide alternative treatments to treat cancer

Revolutionizing Cancer Treatment

AARYA Award

Hon’ble Ministers of State Shri Ashok Chandra Panda, Science & Technology, Public Enterprises, Social Security & Empowerment of Persons with Disability inaugurated the event in the auspicious presence of Padma Vibhusan Pandit Hariprasad Chaurasia and Padmashri Pt. Bhajan Sapori   15 women achievers in distinct categories felicitated with the prestigious award   Parichay Foundation presents…Continue Reading

International Inspirational Women Awards 2020

Top books 2021

16 Best New Drug Delivery Systems Books To Read In 2021 – BookAuthority

error: Content is protected !!